Urine Leucine-Rich α-2 Glycoprotein 1 (LRG1) Predicts the Risk of Progression to End-Stage Kidney Disease in Patients With Type 2 Diabetes.

Authors:
Liu JJ; Liu S; Wang J; Pek SLT; Lee J and 7 more

Journal:
Diabetes Care

Publication Year: 2023

DOI:
10.2337/dc22-1611

PMCID:
PMC9887617

PMID:
36516193

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Diabetes Care

Abbreviation: Diabetes Care

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Endocrinology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Estimating Glycemia From HbA1c and CGM: Analysis of Accuracy and Sources of Discrepancy.
Tozzo V; Genco M; Omololu SO and 12 more (2024) - Transparency Score: 3/6
Euglycemic Ketoacidosis in Two Patients Without Diabetes After Introduction of Sodium-Glucose Cotra…
Umapathysivam MM; Gunton J; Stranks SN and 1 more (2024) - Transparency Score: 2/6
Intensive Lifestyle Intervention for Remission of Early Type 2 Diabetes in Primary Care in Australi…
Hocking SL; Markovic TP; Lee CMY and 3 more (2024) - Transparency Score: 3/6
Longitudinal Assessment of Pancreas Volume by MRI Predicts Progression to Stage 3 Type 1 Diabetes.
Virostko J; Wright JJ; Williams JM and 18 more (2024) - Transparency Score: 3/6
Low-Dose Antithymocyte Globulin: A Pragmatic Approach to Treating Stage 2 Type 1 Diabetes.
Foster TP; Jacobsen LM; Bruggeman B and 11 more (2024) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Duality of Interest. No potential conflicts of interest relevant to this article were reported."

Evidence found in paper:

"Funding. This work was funded by a Singapore National Medical Research Council Clinician Scientist Individual Research grant (MOH-000066) and Khoo Teck Puat Hospital Science Translational and Applied Research grants (18203 and 20201). S.C.L. was partly supported by a Clinician Scientist Award–Investigator (INV/0020/2017) and an Open Fund–Large Collaborative grant (OFLCG/001/2017) from the Singapore National Medical Research Council."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025